Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03956212
Study type Interventional
Source University Medical Centre Ljubljana
Contact
Status Completed
Phase N/A
Start date June 1, 2017
Completion date October 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT01368341 - Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice Phase 4
Completed NCT01518192 - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome Phase 4
Recruiting NCT03966014 - Different Amoxicillin Treatment Regimens in Erythema Migrans Patients N/A
Recruiting NCT03462329 - Patient's Pretreatment Expectations About Post-Lyme Symptoms N/A
Completed NCT03980015 - Inflammatory Responses in Solitary and Multiple Erythema Migrans
Completed NCT03505879 - Next Generation Sequencing Detection of Lyme Disease
Recruiting NCT02147249 - Cytokines and Chemokines in Erythema Migrans N/A
Completed NCT02145754 - Culture Media for Borrelia Burgdorferi Sensu Lato N/A
Completed NCT03371563 - Erythema Migrans in Elderly
Completed NCT02414789 - Lyme Borreliosis and Early Cutaneous Diagnostic N/A
Completed NCT00132327 - Analysis of Lyme Disease Lesions